Is it necessary to undergo both TCT and HPV testing?

With the continuously rising incidence of cervical cancer, TCT (ThinPrep Cytologic Test) and HPV (human papillomavirus) testing—two of the most up-to-date screening methods for cervical cancer—have become essential components of routine health examinations for women. However, many individuals remain unfamiliar with these two tests and are uncertain whether they are necessary. Below, we address the question: Is it necessary to undergo both TCT and HPV testing?

Is it necessary to undergo both TCT and HPV testing?

Yes, undergoing both TCT and HPV testing is recommended. TCT is primarily a cytological examination that analyzes exfoliated cervical cells to determine their type and identify any abnormalities, such as cervical intraepithelial neoplasia (CIN) or invasive carcinoma. Its detection rate for cervical cancer cells approaches 100%. HPV testing, on the other hand, detects the presence of human papillomavirus DNA—specifically in mucus and secretions collected from the cervix or affected areas. Persistent infection with high-risk HPV types significantly increases the risk of developing cervical cancer. In current clinical practice, TCT and HPV testing are routinely performed together, as their combined use greatly enhances the accuracy and effectiveness of cervical cancer screening.

Knowledge Extension: What are the differences between TCT and HPV testing?

1. TCT stands for “ThinPrep Cytologic Test,” a liquid-based cytology technique. It utilizes a thin-layer liquid-based cell preparation system to collect and classify cervical cells for cytological diagnosis. Currently, it represents the most advanced cervical cancer cytology screening method internationally. In addition to detecting precancerous and cancerous cells, TCT can also identify various microbial infections in the vaginal environment—including Candida (yeast), Trichomonas, viruses, and Chlamydia. It is highly effective and widely recommended by physicians for regular screening among women of childbearing age. The TCT cervical cancer screening test achieves a 100% detection rate for abnormal cervical cells and can also identify certain precancerous lesions and common microbial infections such as yeast, Trichomonas, viruses, and Chlamydia.

2. HPV testing involves collecting tissue samples, mucus, or secretions from the lesion site or local cervical area for HPV-DNA analysis to determine whether an HPV infection is present. As HPV predominantly affects mucosal surfaces, sampling is typically performed using a sterile swab to gently collect exfoliated epithelial cells from the cervix. These samples are then analyzed via fluorescence quantitative PCR—a method characterized by high specificity and sensitivity.

The above information addresses the question of whether both TCT and HPV testing are necessary. We hope this overview has been helpful. Wishing you a joyful life and optimal health!